A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT. [Business Insider]
Laboratory Corporation of America Holdings (LH)
Last laboratory corporation of america holdings earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Business Insider
Become an Insider and start reading now. Have an account? Log in Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT). He said everyone should know 4 things before starting TRT. In 2020, longevity researcher Matt Kaeberlein started wondering if he had low testosterone levels. Then, in his early 50s, Kaeberlein had all the classic symptoms: low energy, a substantial drop in libido, and an inability to change his body composition, even though he was consistently strength training and following a balanced diet. "Even though you're working out hard, you're just not seeing loss of fat and increase in muscle," Kaeberlein, now 55, told Business Insider. Kaeberlein saw a doctor and got his testosterone levels tested that year, but it took more testing — and some trial-and-error with medications and supplements — for him to figure out a treatm
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Laboratory Corporation of America Holdings news events
Weekly update
A roundup of the hottest topics
LH
News
- Weitz Partners III Opportunity Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings [Yahoo! Finance]Yahoo! Finance
- Labcorp expands PathAI pact to roll out digital pathology platform in US [Yahoo! Finance]Yahoo! Finance
- Labcorp (NYSE:LH) had its "neutral" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform NationwidePR Newswire
LH
Earnings
- 2/17/26 - Beat
LH
Sec Filings
- 2/27/26 - Form 144
- 2/26/26 - Form 4
- 2/24/26 - Form 10-K
- LH's page on the SEC website